High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types
McGrail, D.J., Pilié, P.G., Rashid, N.U., Voorwerk, L., Slagter, M., Kok, M., Jonasch, E., Khasraw, M., Heimberger, A.B., Lim, B., Ueno, N.T., Litton, J.K., Ferrarotto, R., Chang, J.T., Moulder, S.L., Lin, S.-Y.
Published in Annals of oncology (01.05.2021)
Published in Annals of oncology (01.05.2021)
Get full text
Journal Article
Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma
Zhou, L, Liu, X-D, Sun, M, Zhang, X, German, P, Bai, S, Ding, Z, Tannir, N, Wood, C G, Matin, S F, Karam, J A, Tamboli, P, Sircar, K, Rao, P, Rankin, E B, Laird, D A, Hoang, A G, Walker, C L, Giaccia, A J, Jonasch, E
Published in Oncogene (01.05.2016)
Published in Oncogene (01.05.2016)
Get full text
Journal Article
Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors
Shah, A.Y., Kotecha, R.R., Lemke, E.A., Chandramohan, A., Chaim, J.L., Msaouel, P., Xiao, L., Gao, J., Campbell, M.T., Zurita, A.J., Wang, J., Corn, P.G., Jonasch, E., Motzer, R.J., Sharma, P., Voss, M.H., Tannir, N.M.
Published in European journal of cancer (1990) (01.06.2019)
Published in European journal of cancer (1990) (01.06.2019)
Get full text
Journal Article
Cabozantinib for the treatment of patients with metastatic non-clear cell renal cell carcinoma: A retrospective analysis
Campbell, Matthew T., Bilen, Mehmet A., Shah, Amishi Y., Lemke, Emily, Jonasch, E., Venkatesan, A.M., Altinmakas, E., Duran, C., Msaouel, Pavlos, Tannir, N.M.
Published in European journal of cancer (1990) (01.11.2018)
Published in European journal of cancer (1990) (01.11.2018)
Get full text
Journal Article
High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma
Ho, T H, Park, I Y, Zhao, H, Tong, P, Champion, M D, Yan, H, Monzon, F A, Hoang, A, Tamboli, P, Parker, A S, Joseph, R W, Qiao, W, Dykema, K, Tannir, N M, Castle, E P, Nunez-Nateras, R, Teh, B T, Wang, J, Walker, C L, Hung, M-C, Jonasch, E
Published in Oncogene (24.03.2016)
Published in Oncogene (24.03.2016)
Get full text
Journal Article
Ubiquitination and regulation of AURKA identifies a hypoxia-independent E3 ligase activity of VHL
Hasanov, E, Chen, G, Chowdhury, P, Weldon, J, Ding, Z, Jonasch, E, Sen, S, Walker, C L, Dere, R
Published in Oncogene (15.06.2017)
Published in Oncogene (15.06.2017)
Get full text
Journal Article
A randomized phase 2 study of MK-2206 versus everolimus in refractory renal cell carcinoma
Jonasch, E., Hasanov, E., Corn, P.G., Moss, T., Shaw, K.R., Stovall, S., Marcott, V., Gan, B., Bird, S., Wang, X., Do, K.A., Altamirano, P.F., Zurita, A.J., Doyle, L.A., Lara, P.N., Tannir, N.M.
Published in Annals of oncology (01.04.2017)
Published in Annals of oncology (01.04.2017)
Get full text
Journal Article
Validation of cancer-type-dependent benefit from immune checkpoint blockade in TMB-H tumors identified by the FoundationOne CDx assay
McGrail, D.J., Pilié, P.G., Rashid, N.U., Voorwerk, L., Slagter, M., Kok, M., Jonasch, E., Khasraw, M., Heimberger, A.B., Ueno, N.T., Ferrarotto, R., Chang, J.T., Lin, S.-Y.
Published in Annals of oncology (01.11.2022)
Published in Annals of oncology (01.11.2022)
Get full text
Journal Article
Coordinate phosphorylation of multiple residues on single AKT1 and AKT2 molecules
Guo, H, Gao, M, Lu, Y, Liang, J, Lorenzi, P L, Bai, S, Hawke, D H, Li, J, Dogruluk, T, Scott, K L, Jonasch, E, Mills, G B, Ding, Z
Published in Oncogene (26.06.2014)
Published in Oncogene (26.06.2014)
Get full text
Journal Article
Autophagy mediates HIF2α degradation and suppresses renal tumorigenesis
Liu, X-D, Yao, J, Tripathi, D N, Ding, Z, Xu, Y, Sun, M, Zhang, J, Bai, S, German, P, Hoang, A, Zhou, L, Jonasch, D, Zhang, X, Conti, C J, Efstathiou, E, Tannir, N M, Eissa, N T, Mills, G B, Walker, C L, Jonasch, E
Published in Oncogene (07.05.2015)
Published in Oncogene (07.05.2015)
Get full text
Journal Article
Site-specific activation of AKT protects cells from death induced by glucose deprivation
Gao, M, Liang, J, Lu, Y, Guo, H, German, P, Bai, S, Jonasch, E, Yang, X, Mills, G B, Ding, Z
Published in Oncogene (06.02.2014)
Published in Oncogene (06.02.2014)
Get full text
Journal Article
Reply to: ‘Real-world prevalence across 159 872 patients with cancer supports the clinical utility of TMB-H to define metastatic solid tumors for treatment with pembrolizumab.’ by D. Fabrizio et al
McGrail, D.J., Pilié, P.G., Rashid, N.U., Voorwerk, L., Slagter, M., Kok, M., Jonasch, E., Khasraw, M., Heimberger, A.B., Ueno, N.T., Ferrarotto, R., Chang, J.T., Lin, S.-Y.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma
Zurita, A.J., Jonasch, E., Wang, X., Khajavi, M., Yan, S., Du, D.Z., Xu, L., Herynk, M.H., McKee, K.S., Tran, H.T., Logothetis, C.J., Tannir, N.M., Heymach, J.V.
Published in Annals of oncology (01.01.2012)
Published in Annals of oncology (01.01.2012)
Get full text
Journal Article
Pilot trial of sunitinib therapy in patients with von Hippel–Lindau disease
Jonasch, E., McCutcheon, I.E., Waguespack, S.G., Wen, S., Davis, D.W., Smith, L.A., Tannir, N.M., Gombos, D.S., Fuller, G.N., Matin, S.F.
Published in Annals of oncology (01.12.2011)
Published in Annals of oncology (01.12.2011)
Get full text
Journal Article
Gene and protein expression markers of response to combined antiangiogenic and epidermal growth factor targeted therapy in renal cell carcinoma
Tsavachidou-Fenner, D., Tannir, N., Tamboli, P., Liu, W., Petillo, D., Teh, B., Mills, G.B., Jonasch, E.
Published in Annals of oncology (01.08.2010)
Published in Annals of oncology (01.08.2010)
Get full text
Journal Article
Gevokizumab, an interleukin-1β (IL-1β) monoclonal antibody (mAb), in metastatic colorectal cancer (mCRC), metastatic gastroesophageal cancer (mGEC) and metastatic renal cell carcinoma (mRCC): “first-in-cancer” phase Ib study
Van Cutsem, E., Shitara, K., Deng, W., Vaury, A., Tseng, L., Wang, X., Millholland, J., Shilkrut, M., Mookerjee, B., Jonasch, E.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
Real-world effectiveness of pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma (PRINCIPAL study)
Procopio, G., Bamias, A., Schmidinger, M., Hawkins, R., Rodriguez Sanchez, A., Vazquez, S., Srihari, N., Kalofonos, H., Bono, P., Pisal, C., Hirschberg, Y., Dezzani, L., Ahmad, Q., Suarez Rodriguez, C., Jonasch, E.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Phosphorylation-dependent cleavage regulates von Hippel Lindau proteostasis and function
German, P, Bai, S, Liu, X-D, Sun, M, Zhou, L, Kalra, S, Zhang, X, Minelli, R, Scott, K L, Mills, G B, Jonasch, E, Ding, Z
Published in Oncogene (22.09.2016)
Published in Oncogene (22.09.2016)
Get full text
Journal Article